imiquimod has been researched along with Acute Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abou-Faycal, C; Aouadi, I; Armspach, JP; Bahram, S; Carapito, R; Chatelus, E; De Cauwer, A; Frisch, B; Georgel, P; Macquin, C; Mariotte, A; Paul, N; Pichot, A; Po, C; Sibilia, J | 1 |
| Chen, X; Cheng, L; Dai, L; Deng, H; Deng, J; Li, Y; Lin, Y; Mao, Y; Shi, G; Su, X; Wang, Y; Wei, Y; Yang, Y; Yu, D; Zhang, J; Zhang, S; Zhang, X; Zhang, Y | 1 |
| Amon, LM; Chang, A; Disis, ML; Duan, H; Gad, E; Larson, ER; Lu, H; Tufvesson, H; Van Denend, N; Wagner, WM; Yang, Y | 1 |
| Higgins, SP; McQuillan, O | 1 |
| Bernstein, DI; Harrison, CJ; Miller, RL | 2 |
6 other study(ies) available for imiquimod and Acute Disease
| Article | Year |
|---|---|
A mouse model of MSU-induced acute inflammation
Topics: Acute Disease; Adjuvants, Immunologic; Administration, Topical; Animals; Antioxidants; Cytokines; Disease Models, Animal; Gout; Imiquimod; Inflammation; Injections, Subcutaneous; Interleukin-1beta; Magnetic Resonance Imaging; Mice; Mice, Knockout; Uric Acid | 2020 |
IL-35 recombinant protein reverses inflammatory bowel disease and psoriasis through regulation of inflammatory cytokines and immune cells.
Topics: Acute Disease; Animals; Colitis; Cytokines; Dextran Sulfate; Disease Models, Animal; Female; Humans; Imiquimod; Inflammation Mediators; Inflammatory Bowel Diseases; Interleukins; Lymphocytes; Macrophages; Male; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Phenotype; Psoriasis; Recombinant Proteins; T-Lymphocytes; Vascular Endothelial Growth Factor A | 2018 |
Treatment failure of a TLR-7 agonist occurs due to self-regulation of acute inflammation and can be overcome by IL-10 blockade.
Topics: Acute Disease; Administration, Topical; Aminoquinolines; Animals; CD8-Positive T-Lymphocytes; Growth Inhibitors; Imiquimod; Inflammation Mediators; Interleukin-10; Ligands; Mammary Neoplasms, Experimental; Membrane Glycoproteins; Mice; Mice, Transgenic; Neoplasm Invasiveness; Random Allocation; Receptor, ErbB-2; Toll-Like Receptor 7; Treatment Failure; Up-Regulation | 2010 |
Acute urinary retention following self treatment of genital warts with imiquimod 5% cream.
Topics: Acute Disease; Adjuvants, Immunologic; Adolescent; Aminoquinolines; Condylomata Acuminata; Female; Humans; Imiquimod; Self Administration; Urinary Retention | 2004 |
Adjuvant effects of imiquimod on a herpes simplex virus type 2 glycoprotein vaccine in guinea pigs.
Topics: Acute Disease; Aminoquinolines; Analysis of Variance; Animals; Antibodies, Viral; Drug Synergism; Female; Guinea Pigs; Herpes Simplex; Imiquimod; Interferon Inducers; Random Allocation; Recurrence; Simplexvirus; Vagina; Viral Envelope Proteins; Viral Vaccines; Virus Replication; Virus Shedding | 1993 |
Effects of therapy with an immunomodulator (imiquimod, R-837) alone and with acyclovir on genital HSV-2 infection in guinea-pigs when begun after lesion development.
Topics: Acute Disease; Acyclovir; Aminoquinolines; Animals; Drug Synergism; Drug Therapy, Combination; Female; Ganglia, Spinal; Guinea Pigs; Herpes Genitalis; Imiquimod; Interferon Inducers; Recurrence; Spinal Cord; Vagina; Virus Shedding | 1993 |